Study of poly-L-lactic acid for skin firmness on GLP-1 users
Part of Genetic & congenital, Skin clinical trials.
This study tests whether injections of poly-L-lactic acid (a collagen-boosting filler) can improve loose skin on the belly in women taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to help people who have mild to moderate loose skin and are at a stable weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 65 years old.
- Your skin type is fair to light brown (Fitzpatrick types I–IV).
- You have mild to moderate loose skin on your belly (as determined by a doctor).
- Your weight has been stable for 3 months and your BMI is 27 or less.
- Either you have been on a stable dose of a GLP-1 medication (like Ozempic) for at least 6 months, or you have never taken a GLP-1 medication and don't plan to.
- You are willing to sign consent forms and photo release, and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a topical serum designed to improve visible signs of facial aging, such as fine lines and skin texture. It is looking specifically at men and women aged 25–50 who are already taking a GLP-1 medication like Ozempic, and want to see if adding this serum helps their skin look younger.
This study tests a new facial serum (AGE Serum) designed to improve signs of aging like fine lines and loose skin in post-menopausal women who are taking GLP-1 medications (like Ozempic or Wegovy). Researchers want to see if it's safe and if it actually works to improve how the skin looks.
This trial tests a new injectable collagen product called MEC REGENERATE® to see if it is safe and works well for improving the appearance of facial skin. It may be an option if you are looking for a non-surgical aesthetic treatment.
This trial tests whether a hyaluronic acid filler (a gel injected into the skin) can improve skin quality in women who are taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to see if the filler helps with skin radiance, elasticity, tone, firmness, fine lines, wrinkles, and smoothness.
This trial tests whether a facial filler called Radiesse can restore volume lost during weight loss from GLP-1 medications (like Wegovy or Mounjaro). It's for adults just starting GLP-1 therapy who expect to lose 20 pounds or more and want to see if fillers can help their face look fuller.
This trial tests a micro-coring device called Ellacor® to improve both facial wrinkles and abdominal skin looseness. It is open to people of all skin types and includes those taking certain diabetes/weight-loss medications (GLP-1 agonists).
Hear when a new Laxity; Skin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.